Drgem
At a glance
Drgem filed 14 disclosures in the last 12 months, including 1 contract. The most recent key filing was on Jul 22.
Revenue for 2025 was ₩103B, down 1.2% on 2024. Operating margin was 8.8% against 8.5% a year earlier. Debt was 32% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩57.2B and operating profit of ₩6.2B.
The 2025 annual report lists 276 employees with an average tenure of 4.4 years and average pay of ₩57.1M, #1109 of 1,829 listed companies by average pay. Its 5 directors and auditors were paid ₩243M each on average. It paid ₩178 per common share in cash dividends, against ₩160 a year earlier (+11.3%). 박정병 and related parties held 41.08% at year end.
From the 2025 annual report
Staff: 276 (217 men, 59 women), of whom 5 on fixed-term contracts. Total pay for the year: ₩15.8B. Directors and auditors: 5, paid ₩1.2B in total.
Dividends (common shares)
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash dividend per share | ₩178 | ₩160 | ₩180 |
| Payout ratio | 28.6% | 17.2% | 21.6% |
| Yield (as filed) | 3.25% | 2.83% | 1.71% |
| Total cash dividends | ₩1.9B | ₩1.7B | ₩2B |
Largest shareholder
박정병 holds 30.92%; with 9 related parties the group holds 41.08% of common shares at year end (from 41.09% at the start of the year).
Auditor: 삼화회계법인 · opinion: Unqualified.
Source: 2025 annual business report (DART). How figures are combined
Financial summary
Key filings
Other filings
Links open the original filing on DART, in Korean.